Fumiyo Kitaoka
Overview
Explore the profile of Fumiyo Kitaoka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
963
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miyagawa S, Kawamura T, Ito E, Takeda M, Iseoka H, Yokoyama J, et al.
Stem Cell Res Ther
. 2024 Mar;
15(1):73.
PMID: 38475911
Background: Cell- or tissue-based regenerative therapy is an attractive approach to treat heart failure. A tissue patch that can safely and effectively repair damaged heart muscle would greatly improve outcomes...
2.
Araki H, Miura F, Watanabe A, Morinaga C, Kitaoka F, Kitano Y, et al.
Stem Cell Reports
. 2019 Oct;
13(4):761-774.
PMID: 31564644
The first-in-human trial of induced pluripotent stem cell (iPSC)-based autologous transplantation was successfully performed on a female patient with age-related macular degeneration. Here we delineated the base-resolution methylome of the...
3.
Xu H, Wang B, Ono M, Kagita A, Fujii K, Sasakawa N, et al.
Cell Stem Cell
. 2019 Mar;
24(4):566-578.e7.
PMID: 30853558
Induced pluripotent stem cells (iPSCs) have strong potential in regenerative medicine applications; however, immune rejection caused by HLA mismatching is a concern. B2M gene knockout and HLA-homozygous iPSC stocks can...
4.
Rand T, Sutou K, Tanabe K, Jeong D, Nomura M, Kitaoka F, et al.
Cell Rep
. 2018 Apr;
23(2):361-375.
PMID: 29641997
Here, we report that MYC rescues early human cells undergoing reprogramming from a proliferation pause induced by OCT3/4, SOX2, and KLF4 (OSK). We identified ESRG as a marker of early...
5.
Mandai M, Watanabe A, Kurimoto Y, Hirami Y, Morinaga C, Daimon T, et al.
N Engl J Med
. 2017 Mar;
376(11):1038-1046.
PMID: 28296613
We assessed the feasibility of transplanting a sheet of retinal pigment epithelial (RPE) cells differentiated from induced pluripotent stem cells (iPSCs) in a patient with neovascular age-related macular degeneration. The...
6.
Ameku T, Taura D, Sone M, Numata T, Nakamura M, Shiota F, et al.
Sci Rep
. 2016 Jul;
6:30013.
PMID: 27418197
Cardiovascular complications are the leading cause of death in autosomal dominant polycystic kidney disease (ADPKD), and intracranial aneurysm (ICA) causing subarachnoid hemorrhage is among the most serious complications. The diagnostic...
7.
Kitaoka F, Kakiuchi N, Long C, Itoga M, Mitsue A, Mouri C, et al.
Biol Pharm Bull
. 2009 Apr;
32(4):665-70.
PMID: 19336902
The stems of Akebia plants, Akebiae Caulis, have long been used in traditional Chinese and Japanese medicines, and are mainly produced in western Japan. Three Akebia plants, Akebia quinata (AQ),...
8.
Kitaoka F, Kakiuchi N, Long C, Itoga M, Yoshimatsu H, Mitsue A, et al.
J Nat Med
. 2009 Mar;
63(3):368-74.
PMID: 19277830
The stem of the Akebia plant, "Mokutsu", is a crude diuretic and antiphlogistic drug. Japanese products prepared from wild Akebia plants cover most of the Mokutsu market. Two Akebia plants,...